FIDMAG
- Company typePrivate
- Founded2005
- HeadquartersBarcelona, Spain
- Headcount11–50
- GTM typeB2B
- OfferingServices
What FIDMAG does
FIDMAG is a non-profit biomedical research foundation based in Barcelona, Spain, founded in 2005 and operating under the Hospitalarias Hospital Foundation network. Its core mission is the study of mental illnesses, with a distinctive specialization in the application of structural and functional neuroimaging techniques to severe psychiatric disorders, primarily schizophrenia and bipolar disorder. The foundation functions as both a research organization producing high-impact scientific output (140+ Q1 journal articles over five years with a mean annual impact factor above 5) and a scientific-technical service provider offering five specialized units: Neuroimaging, Biostatistics, Clinical and Cognitive Assessment, Molecular Biology, and Data Management.
Its underlying technology stack centers on multimodal MRI acquisition and analysis, multivariate statistical modeling, and machine learning applied to brain imaging and clinical phenotypic data. FIDMAG maintains clinical and research integration with the Hospital Benito Menni and is a member of the Spanish CIBERSAM network (joined 2008), where since 2022 it coordinates the Schizophrenia Programme. It also participates in the international ENIGMA neuroimaging consortium. The foundation holds CER institutional accreditation (reaccredited 2023) and is recognized as an ISCIII healthcare research support unit.
FIDMAG's business model is that of a publicly funded research foundation: the majority of operating capital comes from competitive public grants (ISCIII, EU/NextGenerationEU, Generalitat de Catalunya, La Caixa Foundation, TV3 Foundation), supplemented by fee-based revenue from six accredited postgraduate training courses (priced between €220 and €1,900 per course) and contract revenue from its scientific-technical service units provided to clinical centers, academic collaborators, and industry partners. It also accepts donations. The foundation does not disclose revenue publicly, and its primary 'customers' are grant bodies, clinical institutions within the Hospitalarias network, and trainees/clinical professionals enrolling in its courses.
FIDMAG firmographics
Firmographics- Name
- FIDMAG
- Legal name
- Fundación para la Investigación y la Docencia María Angustias Giménez (FIDMAG)
- Website
- https://fidmag.org
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
FIDMAG industry classification
Industry- Product category
- Mental Health Research Services
- NAICS
- Research and Development in the Social Sciences and Humanities (541720), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Educational Services (8200)
- akta.pro industry
- Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching)
Keywords
Where FIDMAG is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
FIDMAG business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Training and education services: Organization of specialized training courses for healthcare professionals. Courses are accredited as continuing education by the Catalan Council for Continuing Education of Health Professions. Training is bonifiable through FUNDAE.
- Scientific and technical services: Professionals make their knowledge available to the scientific community to address other projects and scientific challenges. Services include scientific-technical unit, programming unit, neuroimaging unit, statistical support unit, and laboratory unit. These activities are not commercial in nature and generated income is destined for sustainability and the foundational purpose of promoting teaching and research.
- Donations: Accepts donations from the public to advance research in mental health.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Statistics for Health Sciences course |
| Other | Multi-year contract | Resistant Pathologies course |
| Other | Multi-year contract | Electroconvulsive Therapy - 18th edition |
| Other | Multi-year contract | Research Methodology course |
| Other | Multi-year contract | Neuroimaging: analysis and interpretation of results |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
FIDMAG product offering
Product offeringCore offering
FIDMAG is a non-profit research foundation that conducts mental health research, primarily neuroimaging of psychosis (schizophrenia and bipolar disorder), and provides specialized scientific-technical services through five units (Neuroimaging, Programming, Statistical Support, Laboratory, Scientific-Technical). It also offers accredited continuing education training courses for healthcare professionals. Activities are funded by public grants, fee-based services, course fees, and donations, with income reinvested into research and teaching.
Product overview
FIDMAG Germanes Hospitalàries Research Foundation operates as a research institution rather than a commercial product company. Its offerings consist of scientific-technical services and professional training courses. The scientific services include five specialized units: Neuroimaging Unit, Programming Unit, Statistical Support Unit, Laboratory Unit, and Scientific-Technical Unit, all providing research support to the scientific community with revenues directed toward research sustainability. The training portfolio includes six accredited continuing education courses covering statistics, neuroimaging analysis, electroconvulsive therapy, research methodology, resistant pathologies, and REDCap data management.
Differentiator
Problem solved
Functional benefit
Products and services
- Neuroimaging Unit Provides advanced MRI neuroimaging services including structural and functional analysis using advanced magnetic resonance techniques for studying psychiatric disorders, available to the scientific community.
- Programming Unit Offers computational and software development support for research data processing, analysis pipelines, and algorithm development for the scientific community.
- Statistical Support Unit Provides statistical analysis expertise for clinical and translational research studies, including study design and data analysis.
- Laboratory Unit Provides laboratory services supporting neurobiology and genetic research activities.
- Scientific-Technical Unit Offers comprehensive scientific and technical services to the research community for collaborative projects and research challenges.
- Statistics for Health Sciences Course Online continuing education course in statistics for health sciences professionals, accredited by the Catalan Council for Continuing Education of Health Professions.
- Neuroimaging: Analysis and Interpretation of Results Course Comprehensive online course on neuroimaging analysis and interpretation, covering MRI techniques and clinical applications for healthcare professionals.
- Electroconvulsive Therapy Course (18th Edition) Specialized training in electroconvulsive therapy techniques, now in its 18th edition, for mental health professionals.
- Research Methodology Course Online course covering research methodology for clinical and healthcare research settings.
- Resistant Pathologies Course Continuing education course focusing on treatment-resistant psychiatric conditions.
- REDCap Course Training course on REDCap electronic data capture system for clinical research data management.
Quantifiable outcome
- 140+ articles published in first quartile journals in the last five years
- +3 more outcomes
Companies that use FIDMAG
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
FIDMAG technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature3 records
FIDMAG partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core, major and minor.
- CIBERSAM (Centro de Investigación Biomédica en Red de Salud Mental)coreFIDMAG's team led by Dra. Edith Pomarol-Clotet (group G15) is integrated into this excellence network from its creation, collaborating with the best teams in the country. Since 2022, FIDMAG coordinates the Schizophrenia Program and is part of the Steering Committee.
- Fundación Hospitalarias (Hermanas Hospitalarias)coreFIDMAG is part of the Fundación Hospitalarias network, which includes multiple mental health centers across Spain. FIDMAG coordinates research activities across all centers belonging to Fundación Hospitalarias, maintaining close collaboration with psychiatrists, clinical psychologists, and care professionals from these centers.
- ENIGMA ConsortiummajorInternational research consortium for neuroimaging studies in psychiatric disorders. FIDMAG participates in mega-analyses and collaborative research with teams worldwide.
- Various national and international universities and institutionsminorFIDMAG maintains collaborations with other institutions and universities at both national and international levels.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
FIDMAG competitors and assessment
Company assessmentEmerging players
- Alto Neuroscience: Alto Neuroscience is a clinical-stage AI-driven precision psychiatry company developing biomarker-targeted therapeutics for depression and schizophrenia. It is an emerging comparator to FIDMAG's predictive modeling for psychosis risk and treatment response.
- COMPASS Pathways: COMPASS Pathways is a mental health care company developing psilocybin therapy for treatment-resistant depression. Given FIDMAG's research on cannabis and psychosis risk, COMPASS is an emerging thematic peer in psychedelic/CNS psychiatric research.
- Karuna Therapeutics: Karuna Therapeutics developed xanomeline-trospium for schizophrenia treatment and is a leader in CNS drug development for psychiatric disorders. It is a thematic peer in schizophrenia research and would be a natural commercial partner for FIDMAG's schizophrenia neuroimaging data.
Direct peers
- Max Planck Institute of Psychiatry: Max Planck Institute of Psychiatry is a leading European psychiatric research institute conducting neuroimaging, genetics, and clinical studies on depression, schizophrenia, and bipolar disorder. It is comparable to FIDMAG in research domains, mission, and methodology.
- Lieber Institute for Brain Development: Lieber Institute is a non-profit translational neuroscience research organization focused on schizophrenia and related disorders using neuroimaging, genetics, and molecular biology. It is highly comparable to FIDMAG in mission, methods, and disease focus.
- BarcelonaBeta Brain Research Center (BBRC): BBRC is a Barcelona-based research center focused on neuroimaging, Alzheimer's disease, and brain health using advanced MRI and AI. It is a direct peer in neuroimaging-heavy psychiatric/neurological research and shares FIDMAG's Barcelona neuroscience ecosystem.
- IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer): IDIBAPS is a Barcelona-based biomedical research institute focused on translational and clinical research, including neuroscience and psychiatry. Like FIDMAG, it is affiliated with a major hospital, conducts clinical trials, and is integrated into CIBERSAM.
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM): CIBERSAM is the Spanish national mental health research network of which FIDMAG is a founding member. Both organizations conduct psychiatric neuroscience research, train clinical researchers, and channel ISCIII funding — making CIBERSAM the most direct structural peer.
- Hospital del Mar Medical Research Institute (IMIM): IMIM is a Barcelona-based biomedical research institute conducting clinical and translational research with strong neurosciences and mental health programs. It competes with FIDMAG for ISCIII and CIBERSAM funding and serves an overlapping Barcelona academic hospital ecosystem.
- McLean Hospital (Harvard Medical School affiliate): McLean Hospital is a psychiatric hospital affiliated with Harvard Medical School that conducts extensive neuroimaging and clinical research on schizophrenia, bipolar disorder, and other psychiatric illnesses. It is a direct peer in the psychiatric neuroimaging research domain.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
FIDMAG social profiles
Digital presenceFIDMAG financial estimates
Financial estimateRevenue estimate
Valuation estimate
FIDMAG leadership team
Management profileNumber of profiles
Profiles13 records
FIDMAG funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FIDMAG M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FIDMAG
What does FIDMAG do?
FIDMAG is a non-profit research foundation that conducts mental health research, primarily neuroimaging of psychosis (schizophrenia and bipolar disorder), and provides specialized scientific-technical services through five units (Neuroimaging, Programming, Statistical Support, Laboratory, Scientific-Technical). It also offers accredited continuing education training courses for healthcare professionals. Activities are funded by public grants, fee-based services, course fees, and donations, with income reinvested into research and teaching.
Is FIDMAG a public or private company?
FIDMAG is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was FIDMAG founded?
FIDMAG was founded in 2005. It employs 11 to 50 people.
Where is FIDMAG based?
FIDMAG is headquartered in Barcelona, Spain, in the Europe region.
How does FIDMAG make money?
Three revenue lines are on record. Training and education services are the primary driver. The others are scientific and technical services and donations.
Who are FIDMAG's main competitors?
Emerging players on record are Alto Neuroscience, COMPASS Pathways and Karuna Therapeutics. Direct peers are Max Planck Institute of Psychiatry, Lieber Institute for Brain Development, BarcelonaBeta Brain Research Center (BBRC), IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Hospital del Mar Medical Research Institute (IMIM) and McLean Hospital (Harvard Medical School affiliate).
Does FIDMAG have an API?
No public API is recorded for FIDMAG.
What industry is FIDMAG in?
FIDMAG's product category is Mental Health Research Services. Its primary akta.pro industry code is HLALAEAJ, Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching). Its NAICS code is 541720 and its SIC code is 8731.